Keywords
Asthma
Inhaled corticosteroid
Therapeutic adherence
Biological drug
Dupilumab
Abstract
The fractional exhaled nitric oxide (FeNO) is related to the level of eosinophilic inflammation in the airways and the levels of interleukin-13, as such it could be a diagnostic and monitoring tool in asthma. A working group was convened between pulmonologists, respiratory physiology experts, and allergists to establish criteria for the use of FeNO in asthma in Mexico. Through a simplified Delphi method and group discussion, seven key points regarding the use of FeNO were agreed upon. We agree that the measurement of FeNO serves for the diagnosis of asthma in specialized clinics, both in children and adults, as well as to determine the level of corticosteroid treatment. In severe asthma, we recommend FeNO for endotyping, for detecting poor therapeutic adherence, undertreatment, and the risk of crisis. We suggest FeNO can be used to determine the level of corticosteroid treatment and to identify patients at risk of loss of lung function. We also recommend it in adults to improve the selection of biological therapy and, in this context, we only suggest it in selected cases for children.
References
Global Burden of Disease Study 2016 (GBD 2016) data resources [En línea]. EE. UU.: Global Health Data Exchange; 2017. Disponible en: http://ghdx.healthdata.org/gbd-2016
Larenas-Linnemann D, Salas-Hernández J, Vázquez-García JC, Ortiz-Aldana I, Fernández-Vega M, Del Río-Navarro BE, et al. Mexican Asthma Guidelines: GUIMA 2017. Rev Alerg Mex. 2017;64(Suppl 1):s11-s128. DOI: 10.29262/ram.v64i0.272
Bai TR, Vonk JM, Postma DS, Boezen HM. Severe exacerbations predict excess lung function decline in asthma. Eur Respir J. 2007;30(3):452-456. DOI: 10.1183/09031936.00165106
Ortega H, Yancey SW, Keene ON, Gunsoy NB, Albers FC, Howarth PH. Asthma exacerbations associated with lung function decline in patients with severe eosinophilic asthma. J Allergy Clin Immunol Pract. 2018;6(3):980-986.e1. DOI: 10.1016/j.jaip.2017.12.019
Global Strategy for Asthma Management and Prevention. EE. UU.: Global Initiative for Asthma; 2020. Disponible en: https://ginasthma.org/reports/
Fajt ML, Wenzel SE. Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care. J Allergy Clin Immunol. 2015;135(2):299-310;quiz 311. DOI: 10.1016/j.jaci.2014.12.1871
Guía Española para el Manejo del Asma 4.4. España: Luzán 5; 2019. Disponible en: https://www.semg.es/images/documentos/GEMA_4_4.pdf
Godar M, Blanchetot C, de Haard H, Lambrecht BN, Brusselle G. Personalized medicine with biologics for severe type 2 asthma: current status and future prospects. MAbs. 2018;10(1):34-45. DOI: 10.1080/19420862.2017.1392425
Samitas K, Zervas E, Gaga M. T2-low asthma: current approach to diagnosis and therapy. Curr Opin Pulm Med. 2017;23(1):48-55. DOI: 10.1097/MCP.0000000000000342
Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350-400. DOI: 10.1016/S0140-6736(17)30879-6
Wagener AH, de Nijs SB, Lutter R, Sousa AR, Weersink EJ, Bel EH, et al. External validation of blood eosinophils, FE(NO) and serum periostin as surrogates for sputum eosinophils in asthma. Thorax. 2015;70(2):115-120. DOI: 10.1136/thoraxjnl-2014-205634
Westerhof GA, Korevaar DA, Amelink M, de Nijs SB, de Groot JC, Wang J, et al. Biomarkers to identify sputum eosinophilia in different adult asthma phenotypes. Eur Respir J. 2015;46(3):688-696. DOI: 10.1183/09031936.00012415
Malinovschi A, Fonseca JA, Jacinto T, Alving K, Janson C. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects. J Allergy Clin Immunol. 2013;132(4):821-827.e1-5. DOI: 10.1016/j.jaci.2013.06.007
Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society Guideline. Eur Respir J. 2019. DOI: 10.1183/13993003.00588-2019
Soto-Ramos M, Gochicoa-Rangel L, Hinojos-Gallardo LC, Hernández-Saldaña R, Baquera-Arteaga M. Evaluación multidimensional del control en el paciente con asma. Aplicaciones clínicas en la toma de decisiones para el tratamiento. Neumol Cir Torax. 2013;72(1):52-61. Disponible en: https://www.medigraphic.com/pdfs/neumo/nt-2013/nt131i.pdf
Soto-Ramos M, Castro-Rodríguez JA, Hinojos-Gallardo LC, Hernández-Saldaña R, Cisneros-Castolo M, Carrillo-Rodríguez V. Fractional exhaled nitric oxide has a good correlation with asthma control and lung function in latino children with asthma. J Asthma. 2013;50(6):590-594. DOI: 10.3109/02770903.2013.792349
Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602-615. DOI: 10.1164/rccm.9120-11ST
Asthma: diagnosis, monitoring and chronic asthma management [En línea]. Reino Unido: National Institute for Health and Care Excellence; 2017. Disponible en: www.nice.org.uk/guidance/ng80
Petsky HL, Kew KM, Turner C, Chang AB. Exhaled nitric oxide levels to guide treatment for adults with asthma. Cochrane Database Syst Rev. 2016;9(9):CD011440. DOI: 10.1002/14651858.CD011440.pub2
Petsky HL, Kew KM, Chang AB. Exhaled nitric oxide levels to guide treatment for children with asthma. Cochrane Database Syst Rev. 2016;11(11):CD011439. DOI: 10.1002/14651858.CD011439.pub2
Essat M, Harnan S, Gomersall T, Tappenden P, Wong R, Pavord I, et al. Fractional exhaled nitric oxide for the management of asthma in adults: a systematic review. Eur Respir J. 2016;47(3):751-768. DOI: 10.1183/13993003.01882-2015
Lazarus SC, Krishnan JA, King TS, Lang JE, Blake KV, Covar R, et al. Mometasone or tiotropium in mild asthma with a low sputum eosinophil level. N Engl J Med. 2019;380(21):2009-2019. DOI: 10.1056/NEJMoa1814917
Price DB, Buhl R, Chan A, Freeman D, Gardener E, Godley C, et al. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial. Lancet Respir Med. 2018;6(1):29-39. DOI: 10.1016/S2213-2600(17)30424-1
Woo SI, Lee JH, Kim H, Kang JW, Sun YH, Hahn YS. Utility of fractional exhaled nitric oxide (F(E)NO) measurements in diagnosing asthma. Respir Med. 2012;106(8):1103-9.
Sivan Y, Gadish T, Fireman E, Soferman R. The use of exhaled nitric oxide in the diagnosis of asthma in school children. J Pediatr. 2009;155(2):211-216. DOI: 10.1016/j.jpeds.2009.02.034
Malmberg LP, Pelkonen AS, Haahtela T, Turpeinen M. Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma. Thorax. 2003;58(6):494-499. DOI: 10.1136/thorax.58.6.494
Grzelewski T, Witkowski K, Makandjou-Ola E, Grzelewska A, Majak P, Jerzynska J, et al. Diagnostic value of lung function parameters and FeNO for asthma in schoolchildren in large, real-life population. Pediatr Pulmonol. 2014;49(7):632-640. DOI: 10.1002/ppul.22888
Martins C, Silva D, Severo M, Rufo J, Paciencia I, Madureira J, et al. Spirometry-adjusted fraction of exhaled nitric oxide increases accuracy for assessment of asthma control in children. Pediatr Allergy Immunol. 2017;28(8):754-762. DOI: 10.1111/pai.12803
Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath [En línea]. EE. UU.: National Institute for Health and Care Excellence; 2014. Disponible en: https://www.nice.org.uk/guidance/dg12
SIGN 158. British guideline on the management of asthma. A national clinical guideline. Reino Unido: British Thoracic Society/National Health Service Scotland; 2003. Disponible en: https://www.brit-thoracic.org.uk/document-library/guidelines/asthma/btssign-guideline-for-the-management-of-asthma-2019/
Pijnenburg MWH, de Jongste JC. Exhaled nitric oxide in childhood asthma: a review. Clin Exp Allergy. 2008;38(2):246-259. DOI: 10.1111/j.1365-2222.2007.02897.x.
Fleming L, Tsartsali L, Wilson N, Regamey N, Bush A. Longitudinal relationship between sputum eosinophils and exhaled nitric oxide in children with asthma. Am J Respir Crit Care Med. 2013;188(3):400-402. DOI: 10.1164/rccm.201212-2156LE
Pedroletti C, Lundahl J, Alving K, Hedlin G. Exhaled nitric oxide in asthmatic children and adolescents after nasal allergen challenge. Pediatr Allergy Immunol. 2005;16(1):59-64. DOI: 10.1111/j.1399-3038.2005.00200.x
Gaillard EA, McNamara PS, Murray CS, Pavord ID, Shields MD. Blood eosinophils as a marker of likely corticosteroid response in children with preschool wheeze: time for an eosinophil guided clinical trial? Clin Exp Allergy. 2015;45(9):1384-1395. DOI: 10.1111/cea.12535
Wandalsen GF, Solé D, Bacharier LB. Identification of infants and preschool children at risk for asthma: predictive scores and biomarkers. Curr Opin Allergy Clin Immunol. 2016;16(2):120-126. DOI: 10.1097/ACI.0000000000000240
Yao TC, Lee WI, Ou LS, Chen LC, Yeh KW, Huang JL, et al. Reference values of exhaled nitric oxide in healthy Asian children aged 5 to 18 years. Eur Respir J. 2012;39(2):378-384. DOI: 10.1183/09031936.00013911
Pijnenburg MW, Bakker EM, Hop WC, de Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med. 2005;172(7):831-836. DOI: 10.1164/rccm.200503-458OC
De Jongste JC, Carraro S, Hop WC, CHARISM Study Group, Baraldi E. Daily telemonitoring of exhaled nitric oxide and symptoms in the treatment of childhood asthma. Am J Respir Crit Care Med. 2009;179(2):93-97. DOI: 10.1164/rccm.200807-1010OC
Jartti T, Wendelin-Saarenhovi M, Heinonen I, Hartiala J, Vanto T. Childhood asthma management guided by repeated FeNO measurements: a meta-analysis. Paediatr Respir Rev. 2012;13(3):178-183. DOI: 10.1016/j.prrv.2011.11.002
Fritsch M, Uxa S, Horak F, Putschoegl B, Dehlink E, Szepfalusi Z, et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol. 2006;41(9):855-862. DOI: 10.1002/ppul.20455
Lama M, Chatterjee M, Chaudhuri TK. Total serum immunoglobulin E in children with asthma. Indian J Clin Biochem. 2013;28(2):197-200. DOI: 10.1007/s12291-012-0247-2
Suresh V, Mih JD, George SC. Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2007;37(1):97-104. DOI: 10.1165/rcmb.2006-0419OC
Schleich FN, Zanella D, Stefanuto PH, Bessonov K, Smolinska A, Dallinga JW, et al. Exhaled volatile organic compounds are able to discriminate between neutrophilic and eosinophilic asthma. Am J Respir Crit Care Med. 2019;200(4):444-453. DOI: 10.1164/rccm.201811-2210OC
Bradding P. Asthma: eosinophil disease, mast cell disease, or both? Allergy Asthma Clin Immunol. 2008;4(2):84-90. Disponible en: https://aacijournal.biomedcentral.com/articles/10.1186/1710-1492-4-2-84
Zeiger RS, Schatz M, Zhang F, Crawford WW, Kaplan MS, Roth RM, et al. Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol. 2011;128(2):412-414. DOI: 10.1016/j.jaci.2011.06.008
Matsunaga K, Hirano T, Oka A, Ito K, Edakuni N. Persistently high exhaled nitric oxide and loss of lung function in controlled asthma. Allergol Int. 2016;65(3):266-271. DOI: 10.1016/j.alit.2015.12.006
Price D, Ryan D, Burden A, von Ziegenweidt J, Gould S, Freeman D, et al. Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care. Clin Transl Allergy. 2013;3(1):37. Disponible en: https://ctajournal.biomedcentral.com/articles/10.1186/2045-7022-3-37
Hanania NA, Massanari M, Jain N. Measurement of fractional exhaled nitric oxide in real-world clinical practice alters asthma treatment decisions. Ann Allergy Asthma Immunol. 2018;120(4):414-418.e1. DOI: 10.1016/j.anai.2018.01.031
Hekking PP, Wener RR, Amelink M, Zwinderman AH, Bouvy ML, Bel EH. The prevalence of severe refractory asthma. J Allergy Clin Immunol. 2015;135(4):896-902. DOI: 10.1016/j.jaci.2014.08.042
Pavord ID, Afzalnia S, Menzies-Gow A, Heaney LG. The current and future role of biomarkers in type 2 cytokine-mediated asthma management. Clin Exp Allergy. 2017;47(2):148-160. DOI: 10.1111/cea.12881
Tice J, Walsh J, Synnott P, Kumar V, Adair E, Rind D, et al. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks [En línea]. EE. UU.: Institute for Clinical and Economic Review; 2018. Disponible en: https://icer-review.org/wp-content/uploads/2018/04/ICER_Asthma_Draft_Report_092418v1.pdf
Pavord ID, Korn S, Howarth P, Bleecker ER, Buhl R, Keene ON, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):651-659. DOI: 10.1016/S0140-6736(12)60988-X
Wenzel S, Castro M, Corren J, Maspero J, Wang L, Zhang B, et al. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet. 2016;388(10039):31-44. DOI: 10.1016/S0140-6736(16)30307-5
Shrimanker R, Keene O, Hynes G, Wenzel S, Yancey S, Pavord ID. Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis. Am J Respir Crit Care Med. 2019;200(10):1308-1312. DOI: 10.1164/rccm.201903-0599LE
Hanania NA, Wenzel S, Rosen K, Hsieh HJ, Mosesova S, Choy DF, et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am J Respir Crit Care Med. 2013;187(8):804-811. DOI: 10.1164/rccm.201208-1414OC.
Busse WW. Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no! Eur Respir J. 2018;51(5):1800730; DOI: 10.1183/13993003.00730-2018
Attanasi M, Consilvio NP, Rapino D, Nicola MD, Scaparrotta A, Cingolani A, et al. Bronchial hyperresponsiveness to mannitol, airway inflammation and Asthma Control Test in atopic asthmatic children. Arch Med Sci. 2016;12(1):137-144. DOI: 10.5114/aoms.2016.57589
Karrasch S, Linde K, Rucker G, Sommer H, Karsch-Volk M, Kleijnen J, et al. Accuracy of FENO for diagnosing asthma: a systematic review. Thorax. 2017;72(2):109-116. DOI: 10.1136/thoraxjnl-2016-208704
Bannier MA, van de Kant KD, Jöbsis Q, Dompeling E. Biomarkers to predict asthma in wheezing preschool children. Clin Exp Allergy. 2015;45(6):1040-1050. DOI: 10.1111/cea.12460
Pijnenburg MW, Hofhuis W, Hop WC, de Jongste JC. Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission. Thorax. 2005;60(3):215-218. DOI: 10.1136/thx.2004.023374
Stern G, de Jongste J, van der Valk R, Baraldi E, Carraro S, Thamrin C, et al. Fluctuation phenotyping based on daily fraction of exhaled nitric oxide values in asthmatic children. J Allergy Clin Immunol. 2011;128(2):293-300. DOI: 10.1016/j.jaci.2011.03.010
Chang DV, Teper A, Balinotti J, Castro Simonelli C, Garcia-Bournissen F, Kofman C. Exhaled nitric oxide predicts loss of asthma control in children after inhaled corticosteroids withdrawal. Pediatr Pulmonol. 2019;54(5):537-543. DOI: 10.1002/ppul.24268
Petsky HL, Cates CJ, Kew KM, Chang AB. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis. Thorax. 2018;73(12):1110-1119. DOI: 10.1136/thoraxjnl-2018-211540
Syk J, Malinovschi A, Johansson G, Unden AL, Andreasson A, Lekander M, et al. Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial. J Allergy Clin Immunol Pract. 2013;1(6):639-648.e1-8. DOI: 10.1016/j.jaip.2013.07.013
Yuan Y, Li B, Huang M, Peng X, Zhao W, Ye Y, et al. Fractional exhaled nitric oxide was not associated with the future risk of exacerbations in Chinese asthmatics: a non-interventional 1-year real-world study. J Thorac Dis. 2019;11(6):2438-2447. DOI: 10.21037/jtd.2019.05.47
Shrimanker R, Pavord I, Price R, Bradford E, Keene O, Yancey S. Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma. Am J Respir Crit Care Med. 2020;201:A5964. Disponible en: https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A5964
Bjerregaard A, Laing IA, Backer V, Sverrild A, Khoo SK, Chidlow G, et al. High fractional exhaled nitric oxide and sputum eosinophils are associated with an increased risk of future virus-induced exacerbations: a prospective cohort study. Clin Exp Allergy. 2017;47(8):1007-1013. DOI: 10.1111/cea.12935
Wang Z, Pianosi P, Keogh KA, Zaiem F, Alsawas M, Alahdab F, et al. The clinical utility of fractional exhaled nitric oxide (FeNO) in asthma management. Comparat Effectiveness Rev. 2017;197(18). DOI: 10.23970/AHRQEPCCER197.
Kuo CR, Spears M, Haughney J, Smith A, Miller J, Bradshaw T, et al. Scottish consensus statement on the role of FeNO in adult asthma. Respir Med. 2019;155:54-7. DOI: 10.1016/j.rmed.2019.07.010
Diagnosis and management of difficult-to-treat and severe asthma [En línea]. EE. UU.: Global Initiative for Asthma; 2019. Disponible en: https://ginasthma.org/severeasthma/
Nerpin E, Olivieri M, Gislason T, Olin AC, Nielsen R, Johannessen A, et al. Determinants of fractional exhaled nitric oxide in healthy men and women from the European Community Respiratory Health Survey III. Clin Exp Allergy. 2019;49(7):969-979.
Donnelly J, Cowan DC, Yeoman DJ, Lucas SJ, Herbison GP, Thomas KN, et al. Exhaled nitric oxide and pulmonary artery pressures during graded ascent to high altitude. Respiratory physiology & neurobiology. 2011;177(3):213-217. DOI: 10.1111/cea.13394
McDowell KM. Recent diagnosis techniques in pediatric asthma: impulse oscillometry in preschool asthma and use of exhaled nitric oxide. Immunol Allergy Clin North Am. 2019;39(2):205-219. DOI: 10.1016/j.iac.2018.12.002
Gabriele C, de Benedictis FM, de Jongste JC. Exhaled nitric oxide measurements in the first 2 years of life: methodological issues, clinical and epidemiological applications. Ital J Pediatr. 2009;35(1):21. DOI: 10.1186/1824-7288-35-21
Zhang J, Sun Y, Liu M, Sun C, Tian L. Predictive and diagnostic value of fractional exhaled nitric oxide in patients with chronic rhinosinusitis. Med Sci Monit. 2019;25:150-6. DOI: 10.12659/MSM.913295
Daniel PF, Klug B, Valerius NH. Exhaled nitric oxide in healthy young children during tidal breathing through a facemask. Pediatr Allergy Immunol. 2007;18(1):42-46. DOI: 10.1111/j.1399-3038.2006.00473.x
ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912-930. DOI: 10.1164/rccm.200406-710ST
Mattes Joerg, Storm-van’s Gravesande KS, Moeller C, Moseler M, Brandis M, Kuehr J. Circadian variation of exhaled nitric oxide and urinary eosinophil protein X in asthmatic and healthy children. Pediatr Res. 2002;51(2):190-194. DOI: 10.1203/00006450-200202000-00011
Gochicoa-Rangel L, Rojas-Cisneros F, Miguel-Reyes JL, Guerrero-Zuniga S, Mora-Romero U, Maldonado-Mortera AK, et al. Variability of FeNO in healthy subjects at 2240 meters above sea level. J Clin Monit Comput. 2015;30:445-449. DOI: 10.1007/s10877-015-9737-0
Antosova M, Bencova A, Psenkova A, Herle D, Rozborilova E. Exhaled nitric oxide - circadian variations in healthy subjects. Eur J Med Res. 2009;14(Suppl 4):6-8. DOI: 10.1186/2047-783X-14-S4-6
Hacken NH, van der Vaart H, van der Mark TW, Koëter GH, Postma DS. Exhaled nitric oxide is higher both at day and night in subjects with nocturnal asthma. Am J Respir Crit Care Med. 1998;158(3):902-907. DOI: 10.1164/ajrccm.158.3.9712021
Morris NH, Carroll S, Nicolaides KH, Steer PJ, Warren JB. Exhaled nitric oxide concentration and amniotic fluid nitrite concentration during pregnancy. Eur J Clin Invest. 1995;25(2):138-1341. DOI: 10.1111/j.1365-2362.1995.tb01539.x
Lipworth BJ, Jabbal S. Un-diagnosing persistent adult asthma. Eur Respir J. 2017;50(5):1701433. DOI: 10.1183/13993003.01433-2017
Clearie KL, McKinlay L, Williamson PA, Lipworth BJ. Fluticasone/salmeterol combination confers benefits in people with asthma who smoke. Chest. 2012;141(2):330-338. DOI: 10.1378/chest.11-0392
Silkoff PE, Wakita S, Chatkin J, Ansarin K, Gutierrez C, Caramori M, et al. Exhaled nitric oxide after b2-agonist inhalation and spirometry in asthma. Am J Respir Crit Care Med. 1999;159(3):940-944. DOI: 10.1164/ajrccm.159.3.9805044
Wong V, Lerner E. Nitric oxide inhibition strategies. Future Sci OA. 2015;1(1):FSO35. DOI: 10.4155/fso.15.35
Brozek GM, Jankowski M, Zejda JE. Acute respiratory responses to the use of e-cigarette: an intervention study. Sci Rep. 2019;9(1):6844. DOI: 10.1038/s41598-019-43324-1
Lappas AS, Tzortzi AS, Konstantinidi EM, Teloniatis SI, Tzavara CK, Gennimata SA, et al. Short-term respiratory effects of e-cigarettes in healthy individuals and smokers with asthma. Respirology. 2018;23(3):291-297. DOI: 10.1111/resp.13180
Marini S, Buonanno G, Stabile L, Ficco G. Short-term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol. 2014;278(1):9-15. DOI: 10.1016/j.taap.2014.04.004
Dressela H, de la Motte D, Reichert J, Ochmanna U, Petrua R, Angerera P, et al. Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height. Respir Med. 2008;102(7):962-969. DOI: 10.1016/j.rmed.2008.02.012
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med. 2000;162(6):2341-2351. DOI: 10.1164/ajrccm.162.6.ats9-00
Arnold RJ, Massanari M, Lee TA, Brooks E. A review of the utility and cost effectiveness of monitoring fractional exhaled nitric oxide (FeNO) in asthma management. Manag Care. 2018;27(7):34-41. Disponible en: https://www.managedcaremag.com/linkout/2018/7/34
Brooks EA, Massanari M. Cost-effectiveness analysis of monitoring fractional exhaled nitric oxide (FeNO) in the management of asthma. Manag Care. 2018;27(7):42-48. Disponible en: https://www.managedcaremag.com/linkout/2018/7/42
Brooks EA, Massanari M, Hanania NA, Weiner DJ. Cost-effectiveness of fractional exhaled nitric oxide (FeNO) measurement in predicting response to omalizumab in asthma. Clinicoecon Outcomes Res. 2019;11:301-307. DOI: 10.2147/CEOR.S177207
Sabatelli L, Seppälä U, Sastre J, Crater G. Cost-effectiveness and budget impact of routine use of fractional exhaled nitric oxide monitoring for the management of adult asthma patients in Spain. J Investig Allergol Clin Immunol. 2017;27(2):89-97. DOI: 10.18176/jiaci.0103
Bakirtas A. Diagnostic challenges of childhood asthma. Curr Opin Pulm Med. 2017;23(1):27-33. DOI: 10.1097/MCP.0000000000000338
Avital A, Uwyyed K, Berkman N, Godfrey S, Bar-Yishay E, Springer C. Exhaled nitric oxide and asthma in young children. Pediatr Pulmonol. 2001;32(4):308-313. DOI: 10.1002/ppul.1124 95.
Buchvald F, Baraldi E, Carraro S, Gaston B, de Jongste JD, Pijnenburg MWH, et al. Measurementes of exhaled nitric oxide in healty subjects age 4 to 17. J Allergy Clin Immunol. 2005;115(6):1130-1136. DOI: 10.1016/j.jaci.2005.03.020
Gabriele C, Nieuwhof EM, van der Wiel EC, Hofhuis W, Moll HA, Merkus PJ, et al. Exhaled nitric oxide differentiates airway diseases in the first two years of life. Pediatr Res. 2006;60(4):461-465. DOI: 10.1203/01.pdr.0000238242.39881.64
Wildhaber JH, Hall GL, Stick SM. Measurements of exhaled nitric oxide with the single-breath technique and positive expiratory pressure in infants. Am J Respir Crit Care Med. 1999;159(1):74-78. DOI: 10.1164/ajrccm.159.1.9805021
Meyts I, Proesmans M, van Gerven V, Hoppenbrouwers K, de Boeck K. Tidal off-line exhaled nitric oxide measurements in a pre-school population. Eur J Pediatr. 2003;162(7-8):506-510. DOI: 10.1007/s00431-003-1215-x
van der Heijden HH, Brouwer ML, Hoekstra F, van der Pol P, Merkus PJ. Reference values of exhaled nitric oxide in healthy children 1-5 years using off-line tidal breathing. Pediatr Pulmonol. 2014;49(3):291-295. DOI: 10.1002/ppul.22796. Epub 2013 Mar 26
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2020 Revista Alergia México